Domenica Rubino, MD
Enriched profileFounder and Director, Washington Center for Weight Management and Research (Medical Director/Physician) · Washington Center for Weight Management and Research
Domenica Rubino is Founder and Director, Washington Center for Weight Management and Research (Medical Director/Physician) at Washington Center for Weight Management and Research. OpenAlex indexes 83 publications with 8,836 citations (h-index 31); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Domenica M. Rubino, MD, is Founder and Director, Washington Center for Weight Management and Research (Medical Director/Physician). The public record shows 83 publications with 8,836 citations (h-index 31), centered on Obesity. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · Postgraduate medicine
- Top research focus: Obesity
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Impact of the Use of FeelWell™ Compression Garment on Individuals With a BMI ≥35
Sponsor: Feelwell Compression
- Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity
Sponsor: Orexigen Therapeutics, Inc
Industry payments
Updated 15 Oct 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202529 payments$28,205openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year202516 payments$27,615openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202524 payments$17,236openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79%GLP-1 receptor agonist63%Mounjaro73%Ozempic27%Part D<11 patientsBiguanide (metformin)16%Metformin Hcl Er100%Part D<11 patientsCardiovascular
21%Statin10.9%Rosuvastatin Calcium100%Part D<11 patientsPotassium-sparing Diuretic10.1%Triamterene-Hydrochlorothiazid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evidence-informed guidance for the clinical use of oral semaglutide in obesity management.
Postgraduate medicine
Review2026 - CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.
Hypertension (Dallas, Tex.
Clinical Trial2026 - Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials.
Diabetes, obesity & metabolism
Clinical Trial2025 - Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials.
Diabetes, obesity & metabolism
Clinical Trial2024 - A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity.
Diabetes, obesity & metabolism
Article2023
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/domenica-rubino-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/domenica-rubino-41965413
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Domenica-Rubino
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
sciencehub.novonordisk.com/content/sciencehub/global/en/congresses-and-scientific-publications/speakers/domenica-rubino.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sciencehub.novonordisk.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn profile: Domenica Rubino - Director at Washington Center for Weight Management & Research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Rush Medical College (Rush University), Chicago, IL
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗ - Internal Medicine Residency
Rush Presbyterian St. Luke's Medical Center, Chicago, IL
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗
- Board Certified
Obesity Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗ - Board Certified
Endocrinology, Diabetes & Metabolism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗
Editorial & leadership roles
journal and society appointments- Member
American Medical Association, American College of Physicians, American Association of Clinical Endocrinology, Endocrine Society, The Obesity Society, and American Diabetes Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wtmgmt.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →touchendocrinology.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →touchendocrinology.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →touchendocrinology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine